When are we going to celebrate the centenary of the discovery of efficient treatment for congenital toxoplasmosis?

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 2, 2009, Pages 316-319

  Peyron, F ^a  

^a CROIX ROUSSE HOSPITAL   (France)

Author keywords

Congenital toxoplasmosis; Treatment efficacy

Indexed keywords

PROTOZOA; TOXOPLASMA GONDII;

EID: 65549115172     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000200028     Document Type: Article

References (22)

1. Benard A, Petersen E, Salamon R, Chene G, Gilbert R, Salmi L 2008. Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill 13: 6.
2. Binquet C, Wallon M, Metral P, Gadreau M, Quantin C, Peyron F 2004. Toxoplasmosis seroconversion in pregnant women. The differing attitudes in France. Presse Med 33: 775-779.
3. Corvaisier S, Charpiat B, Mounier C, Wallon M, Leboucher G, Al Kurdi M, Chaulet J, Peyron F 2004. Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis. Antimicrob Agents Chemother 48: 3794-3800.
4. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon J, Jenum P, Hedman K, Naessens A 1999. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 180: 410-415.
5. Garin J, Pellerat M, Paillard J, Woerhle B, Hezez R 1968. Bases théoriques de la prévention par la spiramycine de la toxoplasmose congénitale chez la femme enceinte. Presse Med 76: 2268-2271.
6. Garweg J, Scherrer J, Wallon M, Kodjikian L, Peyron F 2005. Reactivation of ocular toxoplasmosis during pregnancy. BJOG 112: 241-242.
7. Gilbert R, Gras L 2003. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 110: 112-120.
8. Gilbert R, Gras L, Wallon M, Peyron F, Ades A, Dun D 2001. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol 30: 1303-1308.
9. Havelaar A, Kemmeren J, Kortbeek L 2007. Disease burden of congenital toxoplasmosis. Clin Infect Dis 44: 1467-1474.
10. Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, MacAleese J, Descombey D, Forestier F 1989. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 115: 765-769.
11. Holland G, Lewis K 2002. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 134: 102-114.
12. Janku J 1923. Pathogenesa a pathologicka anatomie tak nazveneho vrozeneho kolobomu zlute skvrny v oku normalne velikem a mickrophtalmickem s nalezem parasitu v sitnici. Cas Lek Ces 62: 1021-1027.
13. Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J 2008. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr Infect Dis J 27: 27-32.
14. McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N, Jalbrzikowski J, Remington J, Heydemann P, Noble A, Mets, Holfels E, Withers S, Latkany P, Meier P 2006. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis 42: 1383-1394.
15. Montoya JG, Liesenfeld O 2004 Toxoplasmosis. Lancet 363: 1965-1976.
16. Phan L, Kasza K, Jalbrzikowski J, Noble A, Latkany P, Kuo A, Mieler W, Meyers S, Rabiah P, Boyer K, Swisher C, Mets M, Roizen N, Cezar S, Sautter M, Remington J, Meier P, McLeod R 2008. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol 146: 375-384.
17. Sabin AB 1941. Toxoplasmic encephalitis in children, JAMA 116: 807-714.
18. Stanford M, See S, Jones L, Gilbert R 2003. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology 110: 926-931.
19. Thiebaut R, Leproust S, Chene G, Gilbert G 2007. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 369: 115-122.
20. Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C, Peyron F 2004. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113: 1567-1572.
21. Wallon M, Liou C, Garner P, Peyron F 1999. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ 318: 1511-1514.
22. Wol A, Cowen D 1938. Granulomatous encephalomyelitis due to a protozoan (Toxoplasma or Encephalitozoon): II. Identification of a case from the literature. Bull Neurol Inst NY 7: 266-283.